Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

Brain

Volumn 126, Issue 7, 2003, Pages 1628-1637

  Wells, Jennifer E A ^a   Hurlbert, R John ^a   Fehlings, Michael G ^b   Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Inflammation; Minocycline; Neuroprotection; Recovery; Spinal cord injury

Indexed keywords

CYTOKINE; FLUOROGOLD; FREE RADICAL; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MINOCYCLINE;

ANEURYSM CLIP; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; FACILITATION; MALE; MOUSE; MUSCLE STRENGTH; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SPINAL CORD INJURY; STIMULUS RESPONSE; TASK PERFORMANCE; TISSUE INJURY;

EID: 0037481943     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg178     Document Type: Article

References (43)

1. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996; 93: 14014-9.
2. Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxicischemic injury. Ann Neurol 2002; 52: 54-64.
3. Basso DM, Beattie MS, Bresnahan JC. A Sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
4. Bethea JR. Spinal cord injury-induced inflammation: a dual-edged sword. Prog Brain Res 2000; 128: 33-42.
5. Blight AR. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line sampling. Neuroscience 1983; 10: 541-3.
6. Bracken MB. Methylprednisolone and spinal cord injury. J Neurosurg 2002; 96 (1 Suppl): 140-1.
7. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002; 125: 1297-308.
8. Chen M, Ona VO, Li MW, Ferrante RJ, Fink KB, Zhu S, et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000; 6: 797-801.
9. Chikawa T, Ikata T, Katoh S, Hamada Y, Kogure K, Fukuzawa K. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. J Neurotrauma 2001; 18: 93-103.
10. Diaz-Ruiz A, Ibarra A, Perez-Severiano F, Guizar-Sahagun G, Grijalva I, Rios C. Consfitutive and inducible nitric oxide synthase activities after spinal cord contusion in rats. Neurosci Lett 2002; 319: 129-32.
11. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001; 24: 254-64.
12. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994; 6: 712-24.
13. Fehlings MG, Tator CH. The effect of direct current field polarity on recovery after acute experimental spinal cord injury. Brain Res 1992; 579: 32-42.
14. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995; 132: 220-8.
15. Greenberg MS. Handbook of neurosurgery. 4th ed. Lakeland (FL): Greenberg Graphics; 1997.
16. Hall ED. Pharmacological treatment of acute spinal cord injury: how do we build on past success? J Spinal Cord Med 2001; 24: 142-6.
17. He Y, Appel S, Le N. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 2001; 909: 187-93.
18. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000; 93 (1 Suppl): 1-7.
19. Hurlbert RJ. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 2001; 26 (24 Suppl): S39-46.
20. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 2002a; 19: 175-90.
21. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 2002b; 19: 191-203.
22. Kuchler M, Fouad K, Weinmann O, Schwab ME, Raineteau O. Red nucleus projections to distinct motor neuron pools in the rat spinal cord. J Comp Neurol 2002; 448: 349-59.
23. Liu D, Thangnipon W, McAdoo DJ. Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord. Brain Res 1991; 547: 344-8.
24. Molano MR, Broton JG, Bean JA, Calancie B. Complications associated with the prophylactic use of methylprednisolone during surgical stabilization after spinal cord injury. J Neurosurg 2002; 96 (3 Suppl); 96: 267-72.
25. Muir GD, Whishaw IQ. Red nucleus lesions impair overground locomotion in rats: a kinetic analysis. Eur J Neurosci 2000; 12: 1113-22.
26. Nash HH, Borke RC, Anders JJ. Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord. J Neurosci 2002; 22: 7111-20.
27. Nessler S, Dodel R, Bittner A, Reuss S, Du Y, Hemmer B, et al. Effect of minocycline in experimental autoimmune encephalomyelitis. Ann Neurol 2002; 52: 689-90.
28. Paemen L, Martens E, Norga K, Masure S, Roets E, Hoogmartens J, et al. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem Pharmacol 1996; 52: 105-11.
29. Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 2002; 51: 215-23.
30. Rabchevsky AG, Fugaccia I, Sullivan PG, Blades DA, Scheff SW. Efficacy of methylprednisolone therapy for the injured rat spinal cord. J Neurosci Res 2002; 68: 7-18.
31. Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 1988; 15: 355-66.
32. SanchezMejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 2001; 48: 1393-9.
33. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 2001; 26 (24 Suppl): S2-12.
34. Seukeran DC, Eady EA, Cunliffe WJ. Benefit-risk assessment of acne therapies. Lancet 1997; 349: 1251-2.
35. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224-30.
36. Takami T, Oudega M, Bethea JR, Wood PM, Kleitman N, Bunge MB. Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma 2002; 19: 653-66.
37. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001; 21: 2580-8.
38. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 2000; 20: 7037-42.
39. Wilberger JE. Acute spinal cord injury. In: Menezes AH, Sonntag VK, editors. Principles of spinal surgery. New York (NY): McGraw-Hill; 1996. p. 753-67.
40. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002; 22: 1763-71.
41. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2: 502-11.
42. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999; 96: 13496-500.
43. Zhu S, Stavrovskaya I, Drozda M, Kim B, Ona V, Li M, et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002; 417: 74-8.